Tag: financial officer

Ascencio announces the success of a bond offering totalling €32.9 million placed with institutional investors.

Management to discuss second quarter 2026 results and host investor Q&A at virtual event

Ji'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited (“Best Praise”), a company that holds five patents in China with potential applications in pharmaceutical development, for a total purchase price of US$10,751,000, payable in the form of 4,376,552 Class A ordinary shares of the Company.

Generated Record Operating Cash Flow of $54.1 Million; Maintained Profitability 

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, held today its shareholders general meeting at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4^th floor, 75013 Paris, France.

NEW YORK, 25 juin 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome pour développer des thérapies cellulaires et géniques, a tenu son assemblée générale mixte ce jour à 14h30, heure de Paris, à l’auditorium du site Biopark, situé au 11 rue Watt, 4^ème étage, 75013 Paris, France.

LITTLE ROCK, Ark., June 25, 2026 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that it will report its second quarter 2026 financial results prior to the opening of trading on the Nasdaq Stock Exchange on July 30, 2026. A conference call to discuss those earnings will be held the same day at 8:30 AM Eastern Time.